We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-0.75%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.3B
AUM Growth
-$658M
(-3.1%)
Cap. Flow
-$389M
Cap. Flow
% of AUM
-1.92%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,276
New
193
Increased
1,504
Reduced
1,271
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P US Growth ETF
IUSG
|
+$42.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$32.9M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$30.3M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$25.5M |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$90.8M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$78.2M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$51.9M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$49.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$46.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.58% |
| 2 | Consumer Discretionary | 4.97% |
| 3 | Financials | 4.87% |
| 4 | Healthcare | 3.87% |
| 5 | Communication Services | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.86B
| $24.6M | 0.12% |
532,005
+31,229
| +6% | +$1.47M |
|
177
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $24.6M | 0.12% |
632,783
+46,044
| +8% | +$1.81M |
|
178
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
| $24.4M | 0.12% |
169,377
-1,625
| -1% | -$241K |
|
179
First Trust Large Cap Growth AlphaDEX Fund
FTC
$1.38B
| $24.3M | 0.12% |
219,033
+14,846
| +7% | +$1.69M |
|
180
Ford
F
$55.7B
| $24.2M | 0.12% |
1,711,970
-113,900
| -6% | -$1.55M |
|
181
Southern Company
SO
$106B
| $23.8M | 0.12% |
383,978
+5,501
| +1% | +$354K |
|
|
DOCU
182
DocuSign
DOCU
$11.3B
| $23.6M | 0.12% |
91,539
-742
| -0.8% | -$214K |
|
183
Invesco S&P 500 Pure Value ETF
RPV
$1.73B
| $23.6M | 0.12% |
310,838
-28,851
| -8% | -$2.2M |
|
184
Eli Lilly
LLY
$1.08T
| $23.5M | 0.12% |
101,766
-1,782
| -2% | -$440K |
|
185
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.5B
| $23.2M | 0.11% |
312,421
-12,632
| -4% | -$961K |
|
186
First Trust US Equity Opportunities ETF
FPX
$1.49B
| $23.2M | 0.11% |
188,206
+4,340
| +2% | +$552K |
|
187
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $23M | 0.11% |
455,880
-214,320
| -32% | -$11.2M |
|
188
Comcast
CMCSA
$91B
| $22.9M | 0.11% |
408,756
+13,961
| +4% | +$814K |
|
189
Moderna
MRNA
$24.2B
| $22.4M | 0.11% |
58,308
+18,296
| +46% | +$6.75M |
|
190
United Parcel Service
UPS
$88.8B
| $22.4M | 0.11% |
123,093
-10,378
| -8% | -$2.05M |
|
191
Altria Group
MO
$109B
| $22M | 0.11% |
483,496
-14,377
| -3% | -$694K |
|
192
iShares S&P Small-Cap 600 Value ETF
IJS
$8.33B
| $21.9M | 0.11% |
217,120
-155,717
| -42% | -$15.7M |
|
193
CrowdStrike
CRWD
$226B
| $21.7M | 0.11% |
353,752
+7,884
| +2% | +$509K |
|
194
iShares Semiconductor ETF
SOXX
$45.2B
| $21.6M | 0.11% |
145,494
-5,493
| -4% | -$835K |
|
195
ARK Genomic Revolution ETF
ARKG
$1.79B
| $21.6M | 0.11% |
288,860
-27,851
| -9% | -$2.34M |
|
196
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
| $21.5M | 0.11% |
211,054
-1,191
| -0.6% | -$121K |
|
197
VanEck Semiconductor ETF
SMH
$70.6B
| $21.2M | 0.1% |
165,394
+30,978
| +23% | +$4.08M |
|
198
Thermo Fisher Scientific
TMO
$224B
| $21M | 0.1% |
36,681
-5,819
| -14% | -$3.19M |
|
199
Schwab International Equity ETF
SCHF
$68.5B
| $20.9M | 0.1% |
1,081,828
+62,106
| +6% | +$1.24M |
|
200
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.6B
| $20.9M | 0.1% |
444,270
+1,710
| +0.4% | +$82.7K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Cambridge Investment Research Advisors held 3,276 positions worth $20.3B, down 3.1% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q3 2021 filing shows 193 new, 1,504 increased, 1,271 reduced and 193 closed positions. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M. The largest sale was iShares S&P 500 Growth ETF, an estimated $90.8M.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Cambridge Investment Research Advisors's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M.
- Cambridge Investment Research Advisors added most to iShares Core S&P US Growth ETF in Q3 2021, an estimated $42.5M increase.
- Cambridge Investment Research Advisors's biggest Q3 2021 reduction was iShares S&P 500 Growth ETF, cutting an estimated $90.8M.
- Cambridge Investment Research Advisors fully exited VanEck Steel ETF in Q3 2021, selling an estimated $6.22M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $20.3B portfolio in Q3 2021.
- Cambridge Investment Research Advisors opened 193 new positions and closed 193 in Q3 2021.
- Cambridge Investment Research Advisors's portfolio value fell 3.1% quarter-over-quarter to $20.3B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.